Guest guest Posted April 15, 2011 Report Share Posted April 15, 2011 Will CAL-101 participants who receive the daily pill after some study endpoint be allowed to pursue other forms of concurrent treatment while they continue to rely on and respond to CAL-101? Mark Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.